Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck
Go back to Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 107.62 +2.73 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.89 | 52 Week High | $18.39 | |||
| Open | $106.39 | 52 Week Low | $6.96 | |||
| Day High | $107.96 | P/E | N/A | |||
| Day Low | $105.50 | EPS | $-0.58 | |||
| Volume | 2,415,555 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1280.34 +54.61 (4.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1225.73 | 52 Week High | $88.16 | |||
| Open | $1245.81 | 52 Week Low | $67.88 | |||
| Day High | $1292.65 | P/E | 296.38 | |||
| Day Low | $1240.54 | EPS | $4.32 | |||
| Volume | 4,378,466 | |||||
| Medtronic Inc. (NYSE: MDT) | Delayed: 94.13 +2.04 (2.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.09 | 52 Week High | $89.27 | |||
| Open | $92.38 | 52 Week Low | $71.03 | |||
| Day High | $94.72 | P/E | 26.74 | |||
| Day Low | $91.95 | EPS | $3.52 | |||
| Volume | 5,630,712 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.48 +0.77 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.71 | 52 Week High | $59.00 | |||
| Open | $46.01 | 52 Week Low | $32.80 | |||
| Day High | $47.20 | P/E | N/A | |||
| Day Low | $45.84 | EPS | $0.00 | |||
| Volume | 15,690,024 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 45.83 +0.86 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.97 | 52 Week High | $44.76 | |||
| Open | $45.42 | 52 Week Low | $36.81 | |||
| Day High | $46.02 | P/E | N/A | |||
| Day Low | $45.42 | EPS | $0.00 | |||
| Volume | 2,737,836 | |||||

